TABLE 4.
Control1 | Full CL2 | Hemi-CL3 (right side) | |
---|---|---|---|
N | 40 | 28 | 18 |
Body length (mm) | 96 ± 9 | 97 ± 9 | 105 ± 8 |
MRN | 24/65 | 5/12 | 0/7* |
aMRRN | 4/10 | 10/14 | 1/8* |
pMRRN | 9/14 | 12/13 | 8/10 |
PRRN | 11/29 | 13/15 | 4/14* |
PLV | 15/9 | 12/10 | 14/2** |
Transection at 10% BL (2 weeks) → HRP at 20% BL (6 weeks; see Fig. 1A).
Full CL at 30% BL (0 weeks) → transection at 10% BL (2 weeks) → HRP at 20% BL (6 weeks; see Fig. 1B).
Hemi-CL on right side at 30% BL (0 weeks) → transection at 10% BL (2 weeks) → HRP at 20% BL (6 weeks, (11 right and 7 left hemi-CLs; left-right cell counts for left hemi-CL’s were reversed so that the data were normalized for hemi-CLs on the right side, see Fig. 5A).
Numbers of animals in which the cell counts on the (4) contralateral (left) side or (5) ipsilateral (right) side of the brain were greater (see Fig. 5A).
P ≤ 0.05 (Sign test).
P ≤ 0.01 (Sign test).